<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We evaluated and analysed our own 31 cases of the haemorrhagic type of <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e> to clarify the clinical features of this disease </plain></SENT>
<SENT sid="1" pm="."><plain>The cases were divided into three groups </plain></SENT>
<SENT sid="2" pm="."><plain>Group A consisted of 12 cases with <z:hpo ids='HP_0002617'>aneurysms</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0002617'>Aneurysms</z:hpo> on the circle of Willis were treated as ordinary saccular <z:hpo ids='HP_0002617'>aneurysms</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Group B consisted of 14 cases with intracerebral haemorrhage (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e>) without <z:hpo ids='HP_0002617'>aneurysms</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>These were managed almost as spontaneous <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Group C consisted of 5 cases with intraventricular haemorrhage (IVH) without <z:hpo ids='HP_0002617'>aneurysms</z:hpo> or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Twenty-two surgical procedures for <z:hpo ids='HP_0002617'>aneurysms</z:hpo>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e> and IVH were done in 19 cases (62%) </plain></SENT>
<SENT sid="8" pm="."><plain>Nineteen procedures for preventing future <z:hpo ids='HP_0001297'>strokes</z:hpo> were undertaken in 11 cases (35%) </plain></SENT>
<SENT sid="9" pm="."><plain>The overall initial outcome was excellent in 12 cases (39%), good in 7 cases (23%), poor in 7 cases (23%), and <z:hpo ids='HP_0011420'>death</z:hpo> in 5 cases (15%) </plain></SENT>
<SENT sid="10" pm="."><plain>During the follow-up period (mean: 6.5 years), rebleeding occurred in two cases (8%), and ischaemic attacks in two cases (8%) </plain></SENT>
<SENT sid="11" pm="."><plain>The rate of rebleeding or ischaemic attacks was 1.19% per patient-year during the follow-up period </plain></SENT>
<SENT sid="12" pm="."><plain>There was no ischaemic or rebleeding episode in cases treated by STA-<z:chebi fb="70" ids="34342">MCA</z:chebi> bypass with encephalomyosynagiosis (EMS) during the follow-up period </plain></SENT>
<SENT sid="13" pm="."><plain>Management of the primary haemorrhage should be according to the clinical condition, type of haemorrhage, and source of haemorrhage </plain></SENT>
<SENT sid="14" pm="."><plain>When the patient needs to undergo revascularization surgery to prevent future <z:hpo ids='HP_0001297'>strokes</z:hpo>, we recommend STA-<z:chebi fb="70" ids="34342">MCA</z:chebi> bypass with EMS instead of encephaloduro-arteriosynangiosis (EDAS) </plain></SENT>
</text></document>